Govt expects speedy launch of single-dose Sputnik Light vaccine

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been......

Apollo Hospitals launches pilot for Sputnik V vaccine

Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V. IMAGE: Second batch of Sputnik-V......

Sputnik V vaccine to be available in India from next week: Govt

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......

Anti-Covid drug developed by DRDO cleared for emergency use

An anti-COVID oral drug developed by the Defence Research and Development Organisation has been approved by the Drugs Controller General of India for emergency use as an adjunct therapy in moderate......

Mahindra's 3XO Is A Game Changer in Compact SUV Segment

Rajesh Karkera/Rediff.com takes the latest offering from the Mahindra stable for a spin.  Photographs and video: Hitesh Harisinghani/Rediff.com One more XUV (Crossover Utility Vehicle) from......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

Trade generics growth to dent value expansion of domestic drug market

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. Photograph: Jacky Naegelen/Reuters According to a......

Cipla on the block: Who's a better fit and what it means for shareholders?

India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......